Food & Beverages Global On demand · 24-48h

Global Food Encapsulation of New Active Ingredients Market Strategic Research Report

Global Food Encapsulation of New Active Ingredients Market S…
$3,500 USD
Market Research Reports
Strategic Research Report
Global Food Encapsulation of New Active Ingredients Market
$4852025
8.5%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Powder, Granules, Liquid

By Application: Functional Food and Beverages, Convenience Foods, Bakery and Confectionery, Dairy Products, Others

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: dsm-firmenich AG, BASF SE, International Flavors & Fragrances Inc., Givaudan SA, Symrise AG, Kerry Group plc, Glanbia plc, Balchem Corporation, Royal FrieslandCampina N.V., ABF Ingredients Limited, Roquette Frères, AnaBio Technologies Ltd., TasteTech Limited, Maxx Performance, Inc., CABIO Biotech (Wuhan) Co., Ltd., Zhejiang NHU Co., Ltd., INNOBIO CORP LTD, Zhejiang Tianhecheng Bio-technology Shares Co., Ltd., Taiyo Kagaku Co., Ltd., Riken Vitamin Co., Ltd., ILDONG Bioscience Co., Ltd., Cell Biotech Co., Ltd., Ming Chyi Biotechnology Ltd., OmniActive Health Technologies Ltd., Custom Food Ingredients Sdn. Bhd.

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 147 pages
Market size 2025
$485
Million USD
Forecast CAGR
8.5%
2025-2032
Forecast 2032
$858.5
Projected
Gebieden
5
Asia Pacific · Latin America · MEA · Europe · North America

Overzicht

Scope of the Report

The global Food Encapsulation of New Active Ingredients market size is predicted to grow from US$ 485 million in 2025 to US$ 850 million in 2032; it is expected to grow at a CAGR of 8.5% from 2026 to 2032.

Food Encapsulation of New Active Ingredients refers to food-grade functional ingredient systems that use edible wall materials, emulsification systems, gel networks, lipid carriers, protein-polysaccharide complexes, or inclusion materials to convert probiotics, vitamins, minerals, omega-3 fatty acids, carotenoids, polyphenols, botanical extracts, functional peptides, food enzymes, natural colors, and other nutrition-, sensory-, or health-oriented bioactive ingredients into stable powders, granules, microcapsules, liposomes, emulsions, nano-carriers, or premixes. These products are typically composed of a core bioactive ingredient, a protective carrier or wall material, an emulsifying or stabilizing system, and an application-adapted delivery structure. Their core value is to improve processing stability, shelf-life stability, oxidation resistance, solubility, dispersibility, taste masking, controlled release, and bioavailability. Major production and technology bases are located in the United States, Germany, Switzerland, the Netherlands, Ireland, China, Japan, South Korea, and India, with key applications in dietary supplements, functional beverages, dairy products, gummies, bakery products, meal replacements, sports nutrition, infant nutrition, senior nutrition, and specialized nutrition products.

The global market for food encapsulation of new active ingredients is evolving from a conventional ingredient protection technology into a key enabling platform for functional foods, personalized nutrition, and health-oriented consumer products. As consumers place greater emphasis on gut health, immune support, cognitive health, sports recovery, weight management, healthy aging, and natural functional ingredients, food manufacturers increasingly need to incorporate bioactives that are sensitive to oxygen, light, heat, poor solubility, unpleasant taste, or low bioavailability into beverages, dairy products, gummies, powders, meal replacements, and bakery products. Encapsulation technology improves shelf-life stability, processing compatibility, sensory acceptance, and release efficiency without changing the basic food identity of the ingredient, making it an important technical tool for food ingredient companies, nutrition brands, and global food and beverage groups seeking product differentiation.

At the same time, the market continues to face challenges related to cost, regulation, safety data, scale-up consistency, and compliant health claims. High-value liposomal systems, nanoencapsulation, controlled-release particles, and encapsulated probiotics require advanced equipment, suitable wall materials, stability validation, and application data, resulting in longer customer qualification cycles than conventional food ingredients. Over the next few years, growth is expected to concentrate in four commercialized directions: encapsulated probiotics and microbiome ingredients; encapsulated omega-3 fatty acids, fat-soluble vitamins, and carotenoids; encapsulated botanical extracts, polyphenols, and functional peptides; and integrated delivery solutions for gummies, beverages, powders, and ready-to-eat nutrition products. As clean-label, natural-source, low-sugar, high-nutrition, and personalized nutrition trends accelerate, these products are expected to expand from premium nutrition applications into broader daily functional food scenarios.

This report presents a comprehensive overview of the global Food Encapsulation of New Active Ingredients market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • Powder
  • Granules
  • Liquid

Segment by Encapsulation Technology

  • Spray Drying Encapsulation
  • Emulsion and Coacervation Encapsulation
  • Liposomal and Lipid Carrier Encapsulation
  • Extrusion and Other Encapsulation Technologies

Segment by Core Ingredient

  • Vitamins
  • Probiotics and Enzymes
  • Flavors and Colors
  • Minerals and Organic Acids

Segment by Particle Scale

  • Microencapsulation
  • Nanoencapsulation
  • Hybrid Technologies

Segment by Application

  • Functional Food and Beverages
  • Convenience Foods
  • Bakery and Confectionery
  • Dairy Products
  • Others

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Food Encapsulation of New Active Ingredients market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Functional Food and Beverages, Convenience Foods, Bakery and Confectionery evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Food Encapsulation of New Active Ingredients Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 8.5%
Regional growth momentum
Market share by segment
Key metrics
Base value
$485
2025
Forecast
$858.5
2032
CAGR
8.5%
2025–2032
Gebieden
5
global
Key companies
dsm-firmenich AGBASF SEInternational Flavors & Fragrances Inc.Givaudan SASymrise AGKerry Group plcGlanbia plcBalchem Corporation
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
PowderGranulesLiquid
By Application
Functional Food and BeveragesConvenience FoodsBakery and ConfectioneryDairy ProductsOthers

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Powder
  • 3.1.3 Granules
  • 3.1.4 Liquid
  • 3.1.5 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Functional Food and Beverages
  • 4.1.3 Convenience Foods
  • 4.1.4 Bakery and Confectionery
  • 4.1.5 Dairy Products
  • 4.1.6 Others
  • 4.1.7 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 dsm-firmenich AG
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 BASF SE
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 International Flavors & Fragrances Inc.
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 Givaudan SA
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 Symrise AG
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 Kerry Group plc
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 Glanbia plc
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 Balchem Corporation
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 Royal FrieslandCampina N.V.
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 ABF Ingredients Limited
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
  • 8.11 Roquette Frères
  • 8.11.1 Company Overview
  • 8.11.2 Key Products & Segments
  • 8.11.3 Financial Performance (2023–2025)
  • 8.11.4 Business Strategy
  • 8.11.5 SWOT Analysis
  • 8.11.6 Strategic Implications (2026–2032)
  • 8.12 AnaBio Technologies Ltd.
  • 8.12.1 Company Overview
  • 8.12.2 Key Products & Segments
  • 8.12.3 Financial Performance (2023–2025)
  • 8.12.4 Business Strategy
  • 8.12.5 SWOT Analysis
  • 8.12.6 Strategic Implications (2026–2032)
  • 8.13 TasteTech Limited
  • 8.13.1 Company Overview
  • 8.13.2 Key Products & Segments
  • 8.13.3 Financial Performance (2023–2025)
  • 8.13.4 Business Strategy
  • 8.13.5 SWOT Analysis
  • 8.13.6 Strategic Implications (2026–2032)
  • 8.14 Maxx Performance, Inc.
  • 8.14.1 Company Overview
  • 8.14.2 Key Products & Segments
  • 8.14.3 Financial Performance (2023–2025)
  • 8.14.4 Business Strategy
  • 8.14.5 SWOT Analysis
  • 8.14.6 Strategic Implications (2026–2032)
  • 8.15 CABIO Biotech (Wuhan) Co., Ltd.
  • 8.15.1 Company Overview
  • 8.15.2 Key Products & Segments
  • 8.15.3 Financial Performance (2023–2025)
  • 8.15.4 Business Strategy
  • 8.15.5 SWOT Analysis
  • 8.15.6 Strategic Implications (2026–2032)
  • 8.16 Zhejiang NHU Co., Ltd.
  • 8.16.1 Company Overview
  • 8.16.2 Key Products & Segments
  • 8.16.3 Financial Performance (2023–2025)
  • 8.16.4 Business Strategy
  • 8.16.5 SWOT Analysis
  • 8.16.6 Strategic Implications (2026–2032)
  • 8.17 INNOBIO CORP LTD
  • 8.17.1 Company Overview
  • 8.17.2 Key Products & Segments
  • 8.17.3 Financial Performance (2023–2025)
  • 8.17.4 Business Strategy
  • 8.17.5 SWOT Analysis
  • 8.17.6 Strategic Implications (2026–2032)
  • 8.18 Zhejiang Tianhecheng Bio-technology Shares Co., Ltd.
  • 8.18.1 Company Overview
  • 8.18.2 Key Products & Segments
  • 8.18.3 Financial Performance (2023–2025)
  • 8.18.4 Business Strategy
  • 8.18.5 SWOT Analysis
  • 8.18.6 Strategic Implications (2026–2032)
  • 8.19 Taiyo Kagaku Co., Ltd.
  • 8.19.1 Company Overview
  • 8.19.2 Key Products & Segments
  • 8.19.3 Financial Performance (2023–2025)
  • 8.19.4 Business Strategy
  • 8.19.5 SWOT Analysis
  • 8.19.6 Strategic Implications (2026–2032)
  • 8.20 Riken Vitamin Co., Ltd.
  • 8.20.1 Company Overview
  • 8.20.2 Key Products & Segments
  • 8.20.3 Financial Performance (2023–2025)
  • 8.20.4 Business Strategy
  • 8.20.5 SWOT Analysis
  • 8.20.6 Strategic Implications (2026–2032)
  • 8.21 ILDONG Bioscience Co., Ltd.
  • 8.21.1 Company Overview
  • 8.21.2 Key Products & Segments
  • 8.21.3 Financial Performance (2023–2025)
  • 8.21.4 Business Strategy
  • 8.21.5 SWOT Analysis
  • 8.21.6 Strategic Implications (2026–2032)
  • 8.22 Cell Biotech Co., Ltd.
  • 8.22.1 Company Overview
  • 8.22.2 Key Products & Segments
  • 8.22.3 Financial Performance (2023–2025)
  • 8.22.4 Business Strategy
  • 8.22.5 SWOT Analysis
  • 8.22.6 Strategic Implications (2026–2032)
  • 8.23 Ming Chyi Biotechnology Ltd.
  • 8.23.1 Company Overview
  • 8.23.2 Key Products & Segments
  • 8.23.3 Financial Performance (2023–2025)
  • 8.23.4 Business Strategy
  • 8.23.5 SWOT Analysis
  • 8.23.6 Strategic Implications (2026–2032)
  • 8.24 OmniActive Health Technologies Ltd.
  • 8.24.1 Company Overview
  • 8.24.2 Key Products & Segments
  • 8.24.3 Financial Performance (2023–2025)
  • 8.24.4 Business Strategy
  • 8.24.5 SWOT Analysis
  • 8.24.6 Strategic Implications (2026–2032)
  • 8.25 Custom Food Ingredients Sdn. Bhd.
  • 8.25.1 Company Overview
  • 8.25.2 Key Products & Segments
  • 8.25.3 Financial Performance (2023–2025)
  • 8.25.4 Business Strategy
  • 8.25.5 SWOT Analysis
  • 8.25.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

How big is the global Food Encapsulation of New Active Ingredients market?
The global Food Encapsulation of New Active Ingredients market is estimated at US$ 485 million in 2025 (base year) and is projected to reach US$ 850 million by 2032.
How fast is the Food Encapsulation of New Active Ingredients market expected to grow?
The market is expected to grow at a CAGR of 8.5% from 2026 to 2032, expanding from US$ 485 million in 2025 to US$ 850 million in 2032, roughly 1.8 times its base-year value.
What does the Food Encapsulation of New Active Ingredients market cover?
Food Encapsulation of New Active Ingredients refers to food-grade functional ingredient systems that use edible wall materials, emulsification systems, gel networks, lipid carriers, protein-polysaccharide complexes, or inclusion materials to convert probiotics, vitamins, minerals, omega-3 fatty acids, carotenoids, polyphenols, botanical extracts, functional peptides, food enzymes, natural colors, and other nutrition-, sensory-, or health-oriented bioactive ingredients into stable powders, granules, microcapsules, liposomes, emulsions, nano-carriers, or premixes.
How is the Food Encapsulation of New Active Ingredients market segmented by type?
By type, the market is segmented into Powder, Granules and Liquid.
What are the key applications of Food Encapsulation of New Active Ingredients?
Key applications covered include Functional Food and Beverages, Convenience Foods, Bakery and Confectionery, Dairy Products and Others.
Which companies are profiled in the Food Encapsulation of New Active Ingredients market report?
Key players profiled include dsm-firmenich AG, BASF SE, International Flavors & Fragrances Inc., Givaudan SA, Symrise AG, Kerry Group plc, Glanbia plc and Balchem Corporation, among 25 companies covered in total.
What geographies does the Food Encapsulation of New Active Ingredients market analysis include?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What are the main risks and barriers in the Food Encapsulation of New Active Ingredients market?
At the same time, the market continues to face challenges related to cost, regulation, safety data, scale-up consistency, and compliant health claims.
Who should buy the Food Encapsulation of New Active Ingredients market report?
The report is intended for manufacturers and solution providers, distributors and end users in Functional Food and Beverages, Convenience Foods and Bakery and Confectionery, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Food Encapsulation of New Active Ingredients market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

Select a license
from US$ 3.500,00
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.